Güle Çınar

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 929 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting

Burcu Isler, Berna Özer, Güle Çınar et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2022 · 42 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group

Özlem Doğan, Ayşegül Yesilkaya, Şirin Menekşe et al. · International Journal of Antimicrobial Agents · 2020 · 33 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Is pulse oximeter a reliable tool for non‐critically ill patients with COVID‐19?

Aslıhan Gürün Kaya, Miraç Öz, İrem Akdemir Kalkan et al. · International Journal of Clinical Practice · 2021 · 14 citations · Full text

Medicine, Internal Medicine, Critical Care Respiratory Therapy +13

Higher rates of cefiderocol resistance among NDM producing <i>Klebsiella</i> bloodstream isolates applying EUCAST over CLSI breakpoints

Burcu Isler, Cansel Vatansever, Berna Özer et al. · Infectious Diseases · 2023 · 13 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17